Skip to content

The Impact of Rockall Risk Scoring System on Management of Upper Gastrointestinal System Bleeding

The Impact of Rockall Risk Scoring System on Timing of Endoscopy, Length of Hospital Stay, Morbidity and Mortality in Patients With Upper Gastrointestinal System Bleeding

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01269814
Enrollment
100
Registered
2011-01-04
Start date
2010-12-31
Completion date
2013-03-31
Last updated
2012-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Hemorrhage

Keywords

Gastrointestinal bleeding, Emergency endoscopy, Rockall Risk Scoring System

Brief summary

The patients who admit to emergency department with upper gastrointestinal system bleeding will undergo a clinical evaluation with Rockall Risk Scoring System. The patients with Rockall score of 1 or less will be discharged with medical treatment, and will have an elective upper gastrointestinal endoscopy in the end of the 30th day. The impact of Rockall Risk Scoring System on assessing the necessity of emergency endoscopy, length of hospital stay, morbidity, and mortality in low-risk patients will be evaluated.

Detailed description

The patients who admit to emergency department with symptoms of upper gastrointestinal system bleeding will undergo a clinical evaluation. First, diagnosis of upper gastrointestinal system bleeding will be established by combined physical examination and nasogastric tube application. After a certain diagnosis, all of the patients will be scored according to Rockall Risk Scoring System. The patients with a 1 or less Rockall score will have conservative treatment including mucosal protective agent (sucralfat), proton pump inhibitors (omeprazole, lansoprazole, pantoprazole), and hemodynamic monitorization. Should Rockall score and hemodynamic parameters remain unchanged or get improved in the end of 6 hours after admission, oral feeding will be started and the patient will be discharged with anti-ulcer medication (mucosal protective agent and proton pump inhibitor, PO). These patients will be scheduled for upper gastrointestinal endoscopy at 30th day. The patients who have: an initial Rockall score of 2 or greater, an increase in Rockall score or deterioration in hemodynamic parameters during observation, will have emergency endoscopy and will be excluded from the study.

Interventions

PROCEDUREGastroscopy

Gastroscopy

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of upper gastrointestinal system bleeding * Rockall score of 1 or less * Volunteers * Agreement with the terms of informed consent

Exclusion criteria

* Uncertain clinical diagnosis of upper gastrointestinal system bleeding * Rockall score of 2 or greater * Deterioration in hemodynamic parameters during follow-up * Unwilling patients to join the study * Disagreement with the terms of informed consent

Design outcomes

Primary

MeasureTime frame
The necessity of emergency endoscopy.1 month

Secondary

MeasureTime frame
Morbidity1 month
Mortality1 month
Length of hospital stay1 month

Countries

Turkey (Türkiye)

Contacts

Primary ContactOsman Kones, MD
osman.kones@beah.gov.tr090-542-36968282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026